Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor is a research paper published in European Journal of Nuclear Medicine and Molecular Imaging (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA247769
National Institutes of Health
Grant: S10OD023611
National Institutes of Health
Grant: P30CA016086
NCI NIH HHS
Grant: R01 CA247769
National Institutes of Health
Grant: 1S10OD023611-01
Small Animal PET/CT for Preclinical Imaging Research
National Institutes of Health
Grant: 5R01CA247769-03
The development of novel radiation-sensitizer based on ultra-small carbon dots
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
FWCI
3.16
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals